Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 19/20 | 0.51 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7977562 | 1.00 | GNRHR (0.51) | GNRHRCACNA1BCYP3A4 | |
| SCHEMBL8479692 | 0.91 | GNRHR (0.57) | GNRHRCYP3A4 | |
| SCHEMBL8479688 | 0.91 | GNRHR (0.57) | GNRHRCYP3A4 | |
| SCHEMBL7967244 | 0.89 | GNRHR (0.39) | GNRHR | |
| SCHEMBL7967242 | 0.89 | GNRHR (0.39) | GNRHR | |
| SCHEMBL7858393 | 0.84 | GNRHR (0.49) | GNRHR | |
| SCHEMBL8012586 | 0.84 | GNRHR (0.49) | GNRHR | |
| SCHEMBL7967329 | 0.80 | CACNA1B (0.43) | GNRHRCACNA1BCYP3A4 | |
| SCHEMBL7967331 | 0.80 | CACNA1B (0.43) | GNRHRCACNA1BCYP3A4 | |
| SCHEMBL8192232 | 0.78 | GNRHR (0.70) | GNRHRCACNA1BCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6228867-B1 | 2-PHENYL-PYRROLO(2,3-B)PYRIDINE DERIVATIVES FOR TREATING UROGENITAL AND SLEEP DISORDERS; ANTICARCINOGENIC AGENTS; BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. | 2001-05-08 | — | — | US | disclosed |
| US-6110931-A | FOR PREGNANCY PROPHYLAXIS AND TREATMENT OF GLANDULAR DISORDERS, HORMONE DEFICIENCY DISORDERS, GASTROINTESTINAL DISORDERS, GROWTH DISORDERS | MERCK & CO., INC. (US) | 2000-08-29 | — | — | US | disclosed |